CANDELARIA GOMEZ-MANZANO to Glioblastoma
This is a "connection" page, showing publications CANDELARIA GOMEZ-MANZANO has written about Glioblastoma.
Connection Strength
1.581
-
Targeting Innate Immunity in Glioma Therapy. Int J Mol Sci. 2024 Jan 12; 25(2).
Score: 0.428
-
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clin Cancer Res. 2006 Jan 15; 12(2):556-62.
Score: 0.123
-
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
Score: 0.121
-
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics. Neuro Oncol. 2024 01 05; 26(1):127-136.
Score: 0.107
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nat Med. 2023 Jun; 29(6):1370-1378.
Score: 0.102
-
A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-8.
Score: 0.095
-
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg. 2022 Mar 01; 136(3):757-767.
Score: 0.091
-
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models. J Immunother Cancer. 2021 07; 9(7).
Score: 0.090
-
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst. 1997 Jul 16; 89(14):1036-44.
Score: 0.068
-
Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51. Neuro Oncol. 2016 08; 18(8):1109-19.
Score: 0.062
-
Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells. IEEE Trans Nanobioscience. 2015 Dec; 14(8):946-51.
Score: 0.061
-
Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. Br J Cancer. 2013 May 28; 108(10):2005-12.
Score: 0.051
-
Autophagy pathways in glioblastoma. Methods Enzymol. 2009; 453:273-86.
Score: 0.038
-
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity. Cancer Gene Ther. 2009 Mar; 16(3):256-65.
Score: 0.037
-
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
Score: 0.035
-
Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells. Int J Oncol. 2001 Feb; 18(2):343-7.
Score: 0.022
-
Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology. 1998 May; 50(5):1307-15.
Score: 0.018
-
Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. Oncotarget. 2016 May 24; 7(21):30626-41.
Score: 0.016
-
The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010 Oct 15; 70(20):7882-93.
Score: 0.011
-
Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp Cell Res. 1999 Oct 10; 252(1):1-12.
Score: 0.005